Nerve stimulation could help people with fibromyalgia tolerate physical therapy

Publicly released:
International
Photo by Alexey Demidov on Unsplash
Photo by Alexey Demidov on Unsplash

Electrical nerve stimulation could help people with fibromyalgia participate in physical therapy with less pain, according to international researchers. Fibromyalgia is a chronic disorder that causes widespread body pain and fatigue, and while exercise is recommended as a treatment, it can be painful for people with the condition to attempt. Transcutaneous electrical nerve stimulation (TENS) is a treatment that can provide pain relief, and the researchers tested whether it could improve pain in fibromyalgia patients doing physical therapy by recruiting 384 patients and randomising half to receive TENS and physical therapy while the rest just received physical therapy over two months. The researchers say the TENS group reported improvements in movement-related pain relative to the physical therapy-only group, and these improvements were still apparent after six months. In an accompanying editorial, international researchers say TENS shows promise for a condition with few evidence-based treatments, and note the physical therapy-only group had poor outcomes, which reinforces the need for exercise therapy that specifically caters for fibromyalgia patients.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Editorial / Opinion JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Network Open
Research:Paper
Organisation/s: University of Iowa, USA
Funder: This work was supported within the National Institutes of Health (NIH) Pragmatic Trials Collaboratory through the NIH HEAL (Helping to End Addiction Long-Term) Initiative under award UG3/UH3 AR076387 administered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (Drs Crofford and Sluka). Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UM1TR004403. This work also received logistical and technical support from the PRISM Resource Coordinating Center under award U24 AT010961 from the NIH through the NIH HEAL Initiative and from the NIH Pragmatic Trials Collaboratory Coordinating Center under award U24 AT009676 from the National Center for Complementary and Integrative Health, the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Allergy and Infectious Diseases, NIAMS, the National Institute of Minority Health and Health Disparities, the National Institute of Neurological Disorders and Stroke, the National Institute of Nursing Research, the National Institute on Aging, the NIH Office of Behavioral and Social Sciences Research, and the NIH Office of Disease Prevention.
Media Contact/s
Contact details are only visible to registered journalists.